NCT03852017

Brief Summary

In this study, the researchers will examine the implementation feasibility, acceptability, and initial effects of a brief eHealth mindfulness intervention, compared to brief relaxing music, to reduce self-reported symptoms of fatigue, anxiety, depression and sleep disturbance in a sample of localized prostate cancer patients during the receipt of radiation therapy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable prostate-cancer

Timeline
Completed

Started Nov 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 22, 2019

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

2.2 years

First QC Date

December 12, 2018

Last Update Submit

May 4, 2023

Conditions

Keywords

prostate cancermindfulnessmusic

Outcome Measures

Primary Outcomes (4)

  • Implementation feasibility measured by enrollment rate

    This indicator of implementation feasibility for the program being delivered is defined by the overall enrollment rate being \>/= 70% (e.g., total number of individuals enrolled/total number approached).

    Baseline

  • Implementation feasibility measured by retention rate

    This indicator of implementation feasibility for the program delivered is defined by the retention rate being \>/=70% (e.g., total number of individuals who remained in the trial until the end of requested participation/total number of individuals enrolled).

    Throughout study completion, a total of four months.

  • Implementation feasibility measured by intervention adherence

    This indicator of implementation feasibility for the program delivered is defined by an adherence rate of \>/=70% of all possible listening opportunities during the study intervention period.

    Throughout the study intervention period, a total of 4 weeks.

  • Program acceptability measured by a post-program survey at 4-weeks

    Program acceptability will be assessed using a brief, Likert-type survey assessing participant enjoyment, satisfaction, perceived benefit, and ease of use. Acceptability is defined as ≥70% of survey responses in affirmation of this.

    Week 4

Secondary Outcomes (7)

  • Significant change in fatigue using the PROMIS Fatigue questionnaire

    baseline; Week 4; Month 1; Month 3

  • Significant change in anxiety using the PROMIS Anxiety questionnaire

    baseline; Week 4; Month 1; Month 3

  • Change in depression using the PROMIS Depression questionnaire

    baseline; Week 4; Month 1; Month 3

  • Change in sleep using the PROMIS Sleep Disturbance questionnaire

    baseline; Week 4; Month 1; Month 3

  • Change in uncertainty intolerance using the Intolerance for Uncertainty Scale

    baseline; Week 4; Month 1; Month 3

  • +2 more secondary outcomes

Study Arms (2)

Mindfulness Audio Program

EXPERIMENTAL

Mindfulness Audio Program is a daily audio-session, which teaches emotional self-regulation skills through the adoption of mindful awareness practices into one's life

Behavioral: Audio Program

Music Audio Program

ACTIVE COMPARATOR

Music Audio Program is a daily audio session of peaceful and relaxing music

Behavioral: Audio Program

Interventions

Audio ProgramBEHAVIORAL
Mindfulness Audio ProgramMusic Audio Program

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with clinically localized prostate cancer
  • Will receive at least 7 weeks of daily radiation therapy
  • At least 18 years of age
  • Able to speak and understand English
  • Cognitively intact and free of serious psychiatric illness (as determined by referring physician)

You may not qualify if:

  • \- Regular user of mindfulness meditation, which is defined as ≥ 3 times a week for the past 4 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (33)

  • Berkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician. 2010 Aug 15;82(4):381-8, 394.

    PMID: 20704169BACKGROUND
  • Jereczek-Fossa BA, Santoro L, Alterio D, Franchi B, Fiore MR, Fossati P, Kowalczyk A, Canino P, Ansarin M, Orecchia R. Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):403-15. doi: 10.1016/j.ijrobp.2007.01.024. Epub 2007 Mar 29.

    PMID: 17398020BACKGROUND
  • Jereczek-Fossa BA, Marsiglia HR, Orecchia R. Radiotherapy-related fatigue. Crit Rev Oncol Hematol. 2002 Mar;41(3):317-25. doi: 10.1016/s1040-8428(01)00143-3.

    PMID: 11880207BACKGROUND
  • Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007 Oct;105(2):209-19. doi: 10.1007/s10549-006-9447-x. Epub 2007 Jan 3.

    PMID: 17203386BACKGROUND
  • Kawase E, Karasawa K, Shimotsu S, Izawa H, Hirowatari H, Saito AI, Ito K, Horikawa N. Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy. Breast Cancer. 2012 Apr;19(2):147-52. doi: 10.1007/s12282-010-0220-y. Epub 2010 Sep 3.

    PMID: 20814770BACKGROUND
  • Society AC. American Cancer Society Cancer Facts & Figures. Atlanta: American Cancer Society; 2014

    BACKGROUND
  • Garrett K, Dhruva A, Koetters T, West C, Paul SM, Dunn LB, Aouizerat BE, Cooper BA, Dodd M, Lee K, Wara W, Swift P, Miaskowski C. Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. J Pain Symptom Manage. 2011 Aug;42(2):239-50. doi: 10.1016/j.jpainsymman.2010.11.010. Epub 2011 Mar 31.

    PMID: 21454042BACKGROUND
  • Knapp K, Cooper B, Koetters T, Cataldo J, Dhruva A, Paul SM, West C, Aouizerat BE, Miaskowski C. Trajectories and predictors of symptom occurrence, severity, and distress in prostate cancer patients undergoing radiation therapy. J Pain Symptom Manage. 2012 Oct;44(4):486-507. doi: 10.1016/j.jpainsymman.2011.10.020. Epub 2012 Jul 7.

    PMID: 22771128BACKGROUND
  • Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, West C, Aouizerat BE, Dunn L, Swift PS, Wara W. Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep. 2011 Feb 1;34(2):171-9. doi: 10.1093/sleep/34.2.171.

    PMID: 21286498BACKGROUND
  • Mohamed NE, Bovbjerg DH, Montgomery GH, Hall SJ, Diefenbach MA. Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer. Urol Oncol. 2012 Nov-Dec;30(6):804-12. doi: 10.1016/j.urolonc.2011.02.002. Epub 2011 Jul 27.

    PMID: 21795078BACKGROUND
  • Monga U, Garber SL, Thornby J, Vallbona C, Kerrigan AJ, Monga TN, Zimmermann KP. Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy. Arch Phys Med Rehabil. 2007 Nov;88(11):1416-22. doi: 10.1016/j.apmr.2007.08.110.

    PMID: 17964881BACKGROUND
  • Vadiraja HS, Rao MR, Nagarathna R, Nagendra HR, Rekha M, Vanitha N, Gopinath KS, Srinath BS, Vishweshwara MS, Madhavi YS, Ajaikumar BS, Bilimagga SR, Rao N. Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial. Complement Ther Med. 2009 Oct-Dec;17(5-6):274-80. doi: 10.1016/j.ctim.2009.06.004. Epub 2009 Oct 28.

    PMID: 19942107BACKGROUND
  • Portenoy RK. Cancer-related fatigue: An immense problem. Oncologist. 2000;5(5):350-2. doi: 10.1634/theoncologist.5-5-350. No abstract available.

    PMID: 11040269BACKGROUND
  • Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist. 1999;4(1):1-10.

    PMID: 10337366BACKGROUND
  • Kim YH, Kim HJ, Ahn SD, Seo YJ, Kim SH. Effects of meditation on anxiety, depression, fatigue, and quality of life of women undergoing radiation therapy for breast cancer. Complement Ther Med. 2013 Aug;21(4):379-87. doi: 10.1016/j.ctim.2013.06.005. Epub 2013 Jul 6.

    PMID: 23876569BACKGROUND
  • Lengacher CA, Johnson-Mallard V, Barta M, Fitzgerald S, Moscoso MS, Post-White J, Jacobsen PB, Molinari Shelton M, Le N, Budhrani P, Goodman M, Kip KE. Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs. 2011 Jun;29(2):107-17. doi: 10.1177/0898010110385938. Epub 2010 Nov 1.

    PMID: 21041554BACKGROUND
  • Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, Widen RH, Fitzgerald SG, Shelton MM, Barta M, Goodman M, Cox CE, Kip KE. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology. 2009 Dec;18(12):1261-72. doi: 10.1002/pon.1529.

    PMID: 19235193BACKGROUND
  • Gross CR, Kreitzer MJ, Reilly-Spong M, Wall M, Winbush NY, Patterson R, Mahowald M, Cramer-Bornemann M. Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia: a randomized controlled clinical trial. Explore (NY). 2011 Mar-Apr;7(2):76-87. doi: 10.1016/j.explore.2010.12.003.

    PMID: 21397868BACKGROUND
  • Bishop SR, Lau M, Shapiro S, et al. Mindfulness: A Proposed Ooperational Definition. Clinical Psychology: Science and Practice. 2004 2004;11(3):230-241

    BACKGROUND
  • Hulsheger UR, Alberts HJ, Feinholdt A, Lang JW. Benefits of mindfulness at work: the role of mindfulness in emotion regulation, emotional exhaustion, and job satisfaction. J Appl Psychol. 2013 Mar;98(2):310-25. doi: 10.1037/a0031313. Epub 2012 Dec 31.

    PMID: 23276118BACKGROUND
  • Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of your Mind to Face Stress, Pain and Illness. New York: Dell Publishing; 1990

    BACKGROUND
  • Victorson D, Du H, Hankin V, et al. MINDFULNESS BASED STRESS REDUCTION DECREASES FEAR OF PROGRESSION OVER TIME FOR MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE: RESULTS FROM A RANDOMIZED CLINICAL TRIAL. The Journal of Urology. 2012 2012;187(4S):384

    BACKGROUND
  • Victorson DK, M.; Maletich, C.; Lawton, R.C.; Hankin Kaufman, V.; Borrero, M.; Languido, L.; Lewett, K.; Pancoe, H.; Berkowitz, C. . A Systematic Review and Meta-Analysis of Mindfulness-Based Randomized Controlled Trials Relevant to Lifestyle Medicine. . American Journal of Lifestyle Medicine. 2014

    BACKGROUND
  • Vago DR, Silbersweig DA. Self-awareness, self-regulation, and self-transcendence (S-ART): a framework for understanding the neurobiological mechanisms of mindfulness. Front Hum Neurosci. 2012 Oct 25;6:296. doi: 10.3389/fnhum.2012.00296. eCollection 2012.

    PMID: 23112770BACKGROUND
  • Moore A, Gruber T, Derose J, Malinowski P. Regular, brief mindfulness meditation practice improves electrophysiological markers of attentional control. Front Hum Neurosci. 2012 Feb 10;6:18. doi: 10.3389/fnhum.2012.00018. eCollection 2012.

    PMID: 22363278BACKGROUND
  • Jha AP, Krompinger J, Baime MJ. Mindfulness training modifies subsystems of attention. Cogn Affect Behav Neurosci. 2007 Jun;7(2):109-19. doi: 10.3758/cabn.7.2.109.

    PMID: 17672382BACKGROUND
  • Tang YY, Ma Y, Wang J, Fan Y, Feng S, Lu Q, Yu Q, Sui D, Rothbart MK, Fan M, Posner MI. Short-term meditation training improves attention and self-regulation. Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17152-6. doi: 10.1073/pnas.0707678104. Epub 2007 Oct 11.

    PMID: 17940025BACKGROUND
  • Larson MJ, Steffen PR, Primosch M. The impact of a brief mindfulness meditation intervention on cognitive control and error-related performance monitoring. Front Hum Neurosci. 2013 Jul 9;7:308. doi: 10.3389/fnhum.2013.00308. eCollection 2013.

    PMID: 23847491BACKGROUND
  • Dumville JC, Hahn S, Miles JN, Torgerson DJ. The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials. 2006 Feb;27(1):1-12. doi: 10.1016/j.cct.2005.08.003. Epub 2005 Oct 19.

    PMID: 16236557BACKGROUND
  • Wyatt G, Sikorskii A, Rahbar MH, Victorson D, Adams L. Intervention fidelity: aspects of complementary and alternative medicine research. Cancer Nurs. 2010 Sep-Oct;33(5):331-42. doi: 10.1097/NCC.0b013e3181d0b4b7.

    PMID: 20467309BACKGROUND
  • Lai J-S, Cella D, Choi S, Teresi JA, Hays RD, Stone AA. Developing a fatigue item bank for the Patient-Reported Outcomes Measurement Information System (PROMIS FIB version 1). Presented at the Meeting of the Survey Methods in Multicultural, Multinational, and Multiregional Contexts (3MC), Berlin, Germany. 2008

    BACKGROUND
  • Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D; PROMIS Cooperative Group. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment. 2011 Sep;18(3):263-83. doi: 10.1177/1073191111411667. Epub 2011 Jun 21.

    PMID: 21697139BACKGROUND
  • Flynn KE, Shelby RA, Mitchell SA, Fawzy MR, Hardy NC, Husain AM, Keefe FJ, Krystal AD, Porter LS, Reeve BB, Weinfurt KP. Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS((R))). Psychooncology. 2010 Oct;19(10):1086-93. doi: 10.1002/pon.1664.

    PMID: 20013938BACKGROUND

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • David E Victorson, PhD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Following implementation pre-testing, we will use a pilot randomized-controlled design to compare 2 groups: Group A: Mindfulness (n=25), a daily audio-session, which teaches emotional self-regulation skills through the adoption of mindful awareness practices into one's life; and Group B: Relaxing Music (n=25) - a daily audio session of peaceful and relaxing music. Participants will be assessed at baseline just prior to randomization to the two study arms (T1), followed by assessments at the end of the intervention period (T2), and 1 month (T3) and 3 months (T4) after the 4-week intervention period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 12, 2018

First Posted

February 22, 2019

Study Start

November 11, 2015

Primary Completion

January 8, 2018

Study Completion

January 8, 2018

Last Updated

May 6, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share